Novel circulating microRNA signature for early detection and prognostication of checkpoint inhibitor-related pneumonitis
Background Checkpoint inhibitor-related pneumonitis (CIP) represents a highly lethal immune-related adverse event. Early diagnosis of CIP is crucial for timely intervention and improved prognosis; however, the absence of precise and effective diagnostic techniques often leads to underdiagnosis and m...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2025-09-01
|
| Cyfres: | Journal for ImmunoTherapy of Cancer |
| Mynediad Ar-lein: | https://jitc.bmj.com/content/13/9/e012270.full |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
